Kim Hyong
Chief Medical Officer
Kim Hyong has filed 7 SEC Form 4 filings (9 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Oct 7, 2026.
On the most recent filing, Kim Hyong is listed as Chief Medical Officer at Alignment Healthcare, Inc. Inside the rolling window, Kim Hyong reported no open-market purchases and 5 open-market sales totaling $1.9M in ALHC. The largest disclosed transaction in the window is a sale of 35,951 ALHC shares on Jun 12, 2026, worth $714K.
Companies traded
Other insiders at ALHC
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.9M
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has Kim Hyong made?
Kim Hyong has filed 7 SEC Form 4 filings (9 transaction rows) across 1 company since 2025.
Which companies does Kim Hyong trade?
Kim Hyong has filed SEC Form 4 disclosures for 1 company, including ALHC.
When was Kim Hyong's most recent SEC Form 4 filing?
Kim Hyong's most recent SEC Form 4 filing on Tracefour is dated Oct 7, 2026.
What is Kim Hyong's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Kim Hyong is listed as Chief Medical Officer.
What is Kim Hyong's total buy and sell value in the current window?
Inside the rolling retention window, Kim Hyong bought $0 and sold $1.9M based on SEC Form 4 filings.
What was Kim Hyong's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 35,951 ALHC shares on 2026-06-12, worth $714K, per SEC Form 4 filings.